Free Trial
→ Trump’s New Order Could Boost Social Security Benefits by 400% (From InvestorPlace) (Ad) Free RCKT Stock Alerts

Rocket Pharmaceuticals (RCKT) SEC Filings & 10K Form

Rocket Pharmaceuticals logo
$2.90 +0.02 (+0.56%)
Closing price 07/3/2025 03:49 PM Eastern
Extended Trading
$2.89 -0.01 (-0.21%)
As of 07/3/2025 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Rocket Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
07/03/2025
2:17 PM		Ondrey Aaron (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2025
3:52 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
6:43 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/27/2025
6:40 AM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
2:13 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:15 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:17 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Schwartz Jonathan David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:21 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
2:29 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
2:32 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
2:18 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
8:59 AM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/07/2025
9:02 AM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
04/30/2025
3:14 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form DEF 14A
04/30/2025
3:15 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form DEFA14A
04/30/2025
3:16 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form ARS
04/22/2025
2:17 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/14/2025
5:57 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2025
4:10 PM		MAVERICK CAPITAL LTD (Filed by)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form SCHEDULE 13G
04/10/2025
3:07 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
2:26 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2025
3:06 PM		Ondrey Aaron (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
4:24 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
2:25 PM		Ondrey Aaron (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:01 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Schwartz Jonathan David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:01 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
11:56 AM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Schwartz Jonathan David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:29 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:09 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:11 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:11 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
9:25 AM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/05/2025
6:47 PM		Pratumsuwan Piratip (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:43 PM		Pratumsuwan Piratip (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2025
2:15 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
8:28 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
2:33 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
6:38 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
RTW INVESTMENTS, LP (Reporting)
WONG RODERICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
6:51 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13D/A
12/12/2024
5:02 AM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 424B5
11/25/2024
3:05 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Wilson Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad)

Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.

We recently interviewed Rickards to get the full story and understand how everyday Americans can pre
11/25/2024
3:05 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:26 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
3:06 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
2:58 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
2:27 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
3:15 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
9:52 AM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
3:45 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
2:24 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
2:34 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
4:05 PM		Bjork Elisabeth (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:07 PM		Dolsten Mikael (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:05 PM		Dolsten Mikael (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2024
3:06 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:26 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Wilson Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
2:29 PM		Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:39 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:16 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:23 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
3:15 PM		Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
3:05 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
2:22 PM		Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:05 PM		Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
White Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
2:17 PM		Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RCKT) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...
Crypto 101 Media | Sponsored
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...
American Alternative | Sponsored
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored